Vulvar Carcinoma — Trials

Vulvar Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

52 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 26
Recruiting: 13
Ph III recruiting: 0
Growth YoY: —
Industry share: 31%
Top sponsor: Christian Hinrichs
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06358469	STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision(STRIVE)	recruiting	N/A	249	Canadian Cancer Trials GroupNETWORK	2	Aug 11, 2026	clinicaltrials
NCT03713203	PAGETEX® Photodynamic Therapy Device for the Treatment of Extra Mammary Paget's Disease of the Vulva (EMPV).(PAGETEX)	recruiting	N/A	24	University Hospital, LilleOTHER	1	May 5, 2026